Vireo Growth Inc. Announces Closing of Oversubscribed US$81 Million Equity Securities Offering – Oversubscribed equity raise at US$0.625 per share capitalizes Company with a strong
Carol Stafford, Medical Device and Diagnostics Executive, Medidata In the MedTech sector, small and medium-sized organizations are the primary drivers of innovation, developing new technologies
For many of the biggest fish in digital health, 2024 went swimmingly. As the year comes to a close, STAT caught up with leaders from
I think it’s fair to say that everyone expected 2024 to be a little wild, given the U.S. presidential election. But what ended up transpiring
The Food and Drug Administration’s leadership and agenda is about to change, making 2025 a critical year for the agency. With Donald Trump taking office
Arijit Chatterjee, Pharma & Med Tech Solutions Engineering Leader, Capgemini Americas Clinical trials have been the cornerstone of medical innovation for centuries, but as the
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
CDR-404 is under clinical development by CDR-Life and currently in Phase I for Head And Neck Squamous Cell Carcinoma (HNSC).
Vidofludimus calcium is under clinical development by Immunic and currently in Phase III for Coronavirus Disease 2019 (COVID-19).